Woodrum DA

No ORCID on file · 8 papers in corpus
case-report 2025
F&S reports ·doi:10.1016/j.xfre.2025.01.007

ObjectiveTo report a successful case of magnetic resonance imaging (MRI)-guided oocyte retrieval in a patient with challenging pelvic anatomy, extensive adhesive disease, and diminished ovarian reserve, necessitated by the inability to visu…

review 2020
Abdominal radiology (New York) ·doi:10.1007/s00261-019-02379-4

Abdominal wall endometriosis (AWE) is a rare form of endometriosis that often results in substantial pain and debility. The current treatment algorithm for AWE is not well established. The purpose of this review is to describe the Mayo Clin…

rct 2019
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2018.10.032

BACKGROUND: Uterine leiomyomas (fibroid tumors) cause considerable symptoms in 30-50% of women and are the leading cause of hysterectomy in the United States. Women with uterine fibroid tumors often seek uterine-preserving treatments, but c…

rct 2017
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2016.12.177

BACKGROUND: Uterine fibroids are a common problem for reproductive-aged women, yet little comparative effectiveness research is available to guide treatment choice. Uterine artery embolization and magnetic resonance imaging-guided focused u…

rct 2016
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2016.04.001

BACKGROUND: Uterine fibroids are an important source of morbidity for reproductive-aged women. Despite an increasing number of alternatives, hysterectomies account for about 75% of all fibroid interventional treatments. Evidence is lacking …

observational 2013
Journal of therapeutic ultrasound ·doi:10.1186/2050-5736-1-15

BACKGROUND: Magnetic resonance-guided focused ultrasound (MRgFUS) is a relatively new minimally invasive treatment, approved by the US Food and Drug Administration in 2004 for treatments of symptomatic uterine leiomyomas (fibroids). The pur…

rct 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.06.062

OBJECTIVE: To present the rationale, design, and methodology of the Fibroid Interventions: Reducing Symptoms Today and Tomorrow (FIRSTT) study. DESIGN: Randomized clinical trial. SETTING: Two academic medical centers. PATIENT(S): Premeno…

nonrandomized-trial 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.06.004

OBJECTIVE: To determine the feasibility of performing in vivo magnetic resonance elastography (MRE) for uterine leiomyoma. DESIGN: Pilot study. SETTING: Academic medical center. PATIENT(S): Six subjects planning surgical excision of uter…